Suppressors of lapC Mutation Identify New Regulators of LpxC, Which Mediates the First Committed Step in Lipopolysaccharide Biosynthesis

• Published in: International journal of molecular sciences Vol. 24; no. 20; p. 15174
• Main Authors: Maniyeri, Akshay, Wieczorek, Alicja, Ayyolath, Aravind, Sugalska, Weronika, Klein, Gracjana, Raina, Satish
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 14-10-2023; MDPI
• Subjects: acyltransferases LpxL and LpxM; Asymmetry; Bacteria; Biosynthesis; E coli; Enzymes; Genes; Genotype & phenotype; Gram-negative bacteria; LapC and LapD; Lipids; lipopolysaccharide (LPS); LPS assembly proteins LapB; LpxC; MarA; Mutation; Permeability; Proteins; Regulation; Temperature
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms242015174

Gram-negative bacteria, such as Escherichia coli, are characterized by an asymmetric outer membrane (OM) with lipopolysaccharide (LPS) located in the outer leaflet and phospholipids facing the inner leaflet. E. coli recruits LPS assembly proteins LapB, LapC and LapD in concert with FtsH protease to ensure a balanced biosynthesis of LPS and phospholipids. We recently reported that bacteria either lacking the periplasmic domain of the essential LapC protein (lapC190) or in the absence of LapD exhibit an elevated degradation of LpxC, which catalyzes the first committed step in LPS biosynthesis. To further understand the functions of LapC and LapD in regulating LPS biosynthesis, we show that the overproduction of the intact LapD suppresses the temperature sensitivity (Ts) of lapC190, but not when either its N-terminal transmembrane anchor or specific conserved amino acids in the C-terminal domain are mutated. Moreover, overexpression of srrA, marA, yceJ and yfgM genes can rescue the Ts phenotype of lapC190 bacteria by restoring LpxC amounts. We further show that MarA-mediated suppression requires the expression of mla genes, whose products participate in the maintenance of OM asymmetry, and the SrrA-mediated suppression requires the presence of cardiolipin synthase A.